These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 10980142)
1. Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia. Rodriguez-Puebla ML; LaCava M; Miliani De Marval PL; Jorcano JL; Richie ER; Conti CJ Am J Pathol; 2000 Sep; 157(3):1039-50. PubMed ID: 10980142 [TBL] [Abstract][Full Text] [Related]
2. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Robles AI; Larcher F; Whalin RB; Murillas R; Richie E; Gimenez-Conti IB; Jorcano JL; Conti CJ Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7634-8. PubMed ID: 8755527 [TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis. Miliani de Marval PL; Gimenez-Conti IB; LaCava M; Martinez LA; Conti CJ; Rodriguez-Puebla ML Am J Pathol; 2001 Jul; 159(1):369-79. PubMed ID: 11438484 [TBL] [Abstract][Full Text] [Related]
4. Expression of D-type cyclins in normal and neoplastic rat pituitary. Qian X; Kulig E; Jin L; Lloyd RV Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994 [TBL] [Abstract][Full Text] [Related]
5. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
6. Mouse development and cell proliferation in the absence of D-cyclins. Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760 [TBL] [Abstract][Full Text] [Related]
7. Development of mice expressing a single D-type cyclin. Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747 [TBL] [Abstract][Full Text] [Related]
8. Cyclin D2 and cyclin D3 play opposite roles in mouse skin carcinogenesis. Rojas P; Cadenas MB; Lin PC; Benavides F; Conti CJ; Rodriguez-Puebla ML Oncogene; 2007 Mar; 26(12):1723-30. PubMed ID: 16983339 [TBL] [Abstract][Full Text] [Related]
9. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269 [TBL] [Abstract][Full Text] [Related]
12. STAT3 down-regulates the expression of cyclin D during liver development. Matsui T; Kinoshita T; Hirano T; Yokota T; Miyajima A J Biol Chem; 2002 Sep; 277(39):36167-73. PubMed ID: 12147685 [TBL] [Abstract][Full Text] [Related]
13. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Greenhalgh DA; Wang XJ; Donehower LA; Roop DR Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation. Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346 [TBL] [Abstract][Full Text] [Related]
15. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341 [TBL] [Abstract][Full Text] [Related]
16. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649 [TBL] [Abstract][Full Text] [Related]
17. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of D-type G1 cyclins during mouse development and liver regeneration in vivo. Sun W; Lee DK; Lee CC; Kim K Mol Reprod Dev; 1996 Apr; 43(4):414-20. PubMed ID: 9052931 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]